Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer - Yokomizo, Akira; Kanimoto, Yusuke; Okamura, Takehiko; Ozono, Seiichiro; Koga, Hirofumi; Iwamura, Masatsugu; Tanaka, Hiroshi; Takahashi, Satoru; Tsushima, Tomoyasu; Kanayama, Hiro-omi; Akaza, Hideyuki; Shinohara, Nobuo; et al. (The Journal of urology, 2016)
Keywords: Adjuvants, Immunologic - administration & dosage; Adjuvants, Immunologic - adverse effects; administration and dosage; Administration, Intravesical; Aged; BCG Vaccine - administration & dosage; BCG Vaccine - adverse effects; Female; Humans; Male; mycobacterium bovis; Neoplasm Invasiveness; Quality of Life; Treatment Outcome; urinary bladder neoplasms; Urinary Bladder Neoplasms - drug therapy; Urinary Bladder Neoplasms - pathology; Urology; carcinoma in situ; TU; mitomycin C; RCT; bacillus Calmette-Guérin; NMIBC; TURBT; ITT; nonmuscle invasive bladder cancer; intent to treat; PPS; per protocol subjects; transurethral resection of bladder tumor; Club Urológico Español de Tratamiento Oncológico; urinary bladder neoplasms; 1/3D; CUETO; MMC; transurethral; AE; 1/2D; BCG; adverse event; complete response; half dose; CIS; CR; QOL; randomized controlled trial; one-third dose; one-sixth dose; administration and dosage; mycobacterium bovis; 1/6D; quality of life